相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A New Heterotopic Transplant Animal Model of Intestinal Fibrosis
Martin Hausmann et al.
INFLAMMATORY BOWEL DISEASES (2013)
Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease
Florian Rieder et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
A Controlled Clinical Trial With Pirfenidone in the Treatment of Pathological Skin Scarring Caused by Burns in Pediatric Patients
Juan Armendariz-Borunda et al.
ANNALS OF PLASTIC SURGERY (2012)
Intestinal fibrosis is reduced by early elimination of inflammation in a mouse model of IBD: Impact of a Top-Down approach to intestinal fibrosis in mice
Laura A. Johnson et al.
INFLAMMATORY BOWEL DISEASES (2012)
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
Paul W. Noble et al.
LANCET (2011)
Antifibrotic activities of pirfenidone in animal models
C. J. Schaefer et al.
EUROPEAN RESPIRATORY REVIEW (2011)
Antifibrotic action of pirfenidone and prednisolone: Different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis
Hisashi Oku et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Cellular and molecular mechanisms of fibrosis
T. A. Wynn
JOURNAL OF PATHOLOGY (2008)
Review article: the burden of hepatic encephalopathy
F. F. Poordad
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Healing and fibrosis in intestinal disease
F. Rieder et al.
GUT (2007)
Attenuation of dextran sodium sulphate induced colitis in matrix metalloproteinase-9 deficient mice
Alfredo Santana et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure
Ken W. Lee et al.
CIRCULATION (2006)
Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: Central role of epithelial-derived MMP
FE Castaneda et al.
GASTROENTEROLOGY (2005)
Expression of matrix metalloproteinases-2 and-9 in intestinal tissue of patients with inflammatory bowel diseases
Q Gao et al.
DIGESTIVE AND LIVER DISEASE (2005)
Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery
J Cosnes et al.
GUT (2005)
The anti-fibrotic effect of pirfenidone in rat liver fibrosis is mediated by downregulation of procollagen α1(I), TIMP-1 and MMP-2
A Di Sario et al.
DIGESTIVE AND LIVER DISEASE (2004)
Natural history and clinical behavior of Crohn's disease extending beyond two decades
HJ Freeman
JOURNAL OF CLINICAL GASTROENTEROLOGY (2003)
Reduced migration of fibroblasts in inflammatory bowel disease: Role of inflammatory mediators and focal adhesion kinase
SN Leeb et al.
GASTROENTEROLOGY (2003)
Effect of pirfenidone against vanadate-induced kidney fibrosis in rats
MA Al-Bayati et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Long-term evolution of disease behavior of Crohn's disease
J Cosnes et al.
INFLAMMATORY BOWEL DISEASES (2002)
Regulation of migration of human colonic myofibroblasts
SN Leeb et al.
GROWTH FACTORS (2002)
Regulation of hepatic fibrosis and extracellular matrix genes by the Th response: New insight into the role of tissue inhibitors of matrix metalloproteinases
B Vaillant et al.
JOURNAL OF IMMUNOLOGY (2001)
Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease
B von Lampe et al.
GUT (2000)
分享论文
